Listening: The Alzheimer's Dilemma
Audiție: Dilema Alzheimer. Ascultă o ședință a unui panel de experți și răspunde la întrebări. Acest exercițiu dezvoltă înțelegerea detaliilor din discuțiile științifice despre anticorpi monoclonali.
Аудирование: Дилемма об Альцгеймере. Прослушайте закрытое заседание экспертного совета по оценке нового препарата и ответьте на вопросы. Упражнение развиваетвыделение ключевых деталей в научных дискуссиях.
The Alzheimer's Dilemma
A closed-door panel meeting at the FDA headquarters in Washington, D.C., evaluating a new monoclonal antibody.
The Alzheimer's Dilemma
True or false?
The drug under discussion is a monoclonal antibody for early Alzheimer's.
- True
- False
The pivotal trial showed a massive and undeniable improvement in cognitive function.
- True
- False
Brain swelling rates observed in the trials are causing serious concern among experts.
- True
- False
All three committee members agree that the approval decision will be completely uncontroversial.
- True
- False
The committee plans to review the rolling submission data again before voting.
- True
- False
Listen again and complete the sentences
- Noah: Welcome, everyone. We're here to discuss Aducanzumab-beta, the new monoclonal antibody for early Alzheimer's. Let's review the clinical data before we vote on the accelerated ____ .
- Amanda: Noah, we've looked at the ____ results closely. It's clear that the surrogate endpoint of amyloid plaque reduction was met, but the cognitive decline is barely slowed.
- Kevin: So we're trapped between public outrage and scientific rigor. Let's examine the ____ data once more before casting our votes.
Sources: photo by DΛVΞ GΛRCIΛ on Pexels
Despre această lecție
Acest curs de engleză medicală la nivel avansat (C1-C2) se adresează medicilor consultanți, profesorilor și cercetătorilor care colaborează cu instituții din SUA și Marea Britanie. Lecția de astăzi explorează procesul complex de aprobare a unui medicament inovator și deciziile etice aferente.
Об этом уроке
Этот урок продвинутого уровня английского языка (C1-C2) предназначен для врачей-консультантов, преподавателей и исследователей, сотрудничающих с учреждениями США и Великобритании. На уроке рассматривается сложный процесс одобрения инновационного препарата и связанные с ним этические решения.